Clinical Genomic Testing: Getting It Right



  1. 1.
    Billingham, M., Barboe, C. C., Berry, G., Kobashigawa, J., Johnson, F. L., Starling, R. C., et al. (2006). Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. American Journal of Transplantation, 6, 150–160.PubMedCrossRefGoogle Scholar
  2. 2.
    Burke, W. (2002). Genetic testing. New England Journal of Medicine, 347, 1867–1875.PubMedCrossRefGoogle Scholar
  3. 3.
    Fryback D. G., & Thornbury J. R. (1991). The efficacy of diagnostic imaging. Medical Decision Making, 11, 88–94.PubMedCrossRefGoogle Scholar
  4. 4.
    Guyatt G. H., Tugwell P. X., Feeny D. H., Haynes R. B., & Drummond M. (1986). A framework for clinical evaluation of diagnostic technologies. CMAJ , 134, 587–594.PubMedGoogle Scholar
  5. 5.
    Haga S. B., & Willard H. F. (2006). Defining the spectrum of genome policy. Nature Reviews. Genetics, 7(12), 966–972 Dec.PubMedCrossRefGoogle Scholar
  6. 6.
    Kohane I. S., Masys D. R., & Altman R. B. (2006). The incidentalome: A threat to genomic medicine. Journal of the American Medical Association, 296(2), 212–215 Jul 12.PubMedCrossRefGoogle Scholar
  7. 7.
    Miller, M. E. (2005). Medical Payment Advisory Commission (MedPAC) recommendations on imaging services. Testimony before the Subcommittee on Health, Committee on Ways and Means, US House of Representatives, March 17, 2005. Retrieved November 14, 2007 from
  8. 8.
    Rosenwald, M. (2005). What is the future of diagnostic medicine? Popular Science, July.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of MedicineDuke University Medical CenterDurhamUSA
  2. 2.Duke Clinical Research InstituteDurhamUSA
  3. 3.Center for Genomic MedicineDuke Institute for Genome Sciences and PolicyDurhamUSA

Personalised recommendations